Clinical Trial Update: Curcumin + Aminosalicylic Acid (5ASA) Versus 5ASA Alone in the Treatment of Mild to Moderate Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing curcumin added to 5-aminosalicylate therapy versus 5-ASA alone for mild to moderate ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• 5-aminosalicylic acid (mesalamine) (mesalamine)
• Curcumin (curcumin)

Snippet

Sponsor: Sheba Medical Center | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED